Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria

Abstract Background In Nigeria, Artemisinin-based Combination Therapy (ACT) is the recommended first line antimalarial medicine for uncomplicated malaria. However, health care providers still continue the use of less efficacious medicines such as Sulphadoxine-pyrimethamine and chloroquine. We theref...

Full description

Bibliographic Details
Main Authors: Sylvanus C. Welle, Olufemi Ajumobi, Magbagbeola Dairo, Muhammad Balogun, Peter Adewuyi, Babatunde Adedokun, Patrick Nguku, Saheed Gidado, IkeOluwapo Ajayi
Format: Article
Language:English
Published: BMC 2019-01-01
Series:Global Health Research and Policy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41256-018-0092-9
_version_ 1828807762170085376
author Sylvanus C. Welle
Olufemi Ajumobi
Magbagbeola Dairo
Muhammad Balogun
Peter Adewuyi
Babatunde Adedokun
Patrick Nguku
Saheed Gidado
IkeOluwapo Ajayi
author_facet Sylvanus C. Welle
Olufemi Ajumobi
Magbagbeola Dairo
Muhammad Balogun
Peter Adewuyi
Babatunde Adedokun
Patrick Nguku
Saheed Gidado
IkeOluwapo Ajayi
author_sort Sylvanus C. Welle
collection DOAJ
description Abstract Background In Nigeria, Artemisinin-based Combination Therapy (ACT) is the recommended first line antimalarial medicine for uncomplicated malaria. However, health care providers still continue the use of less efficacious medicines such as Sulphadoxine-pyrimethamine and chloroquine. We therefore determined preference for ACT (PFA) and factors associated with PFA among healthcare providers (HCP) in Lokoja, North-Central Nigeria as well as assessed healthcare providers’ knowledge of malaria case management. Methods We conducted a cross-sectional study among physicians, nurses, pharmacists, community health officers (CHOs), community health extension workers (CHEWs) and, patent and proprietary medicine vendors (PPMVs). Interviewer-administered questionnaires were administered to collect data on respondents’ characteristics, previously received malaria case management training and knowledge of malaria treatment. Knowledge scores ≥3 were categorised as good, maximum obtainable being 5. Results Of the 404 respondents, 214 (53.0%) were males. Overall, 219 (54.2%) respondents who received malaria case management training  included PPMVs: 79 (65.8%), CHEWs: 25 (64.1%), CHOs: 5 (55.6%), nurses: 72 (48.7%), physicians: 35 (47.3%) and pharmacists: 3 (23.1%). Overall, 202 (50.0%) providers including physicians: 69 (93.2%), CHO: 8 (88.9%), CHEWs: 33 (84.6%), pharmacists: 8 (61.5%), nurses: 64 (43.2%) and PPMVs: 20 (16.5%), had good knowledge of malaria treatment guidelines. Overall, preference for ACT among healthcare providers was 39.6%. Physicians: 50 (67.6%), pharmacists: 7 (59.3%) CHOs: 5 (55.6%), CHEWS: 16 (41.0%), nurses: 56 (37.8%) and PPMV: 24 (19.8%) had PFA. Receiving malaria case management training (adjusted odds ratio [aOR]) = 2.3; CI = 1.4 – 3.7) and having good knowledge of malaria treatment (aOR = 4.0; CI = 2.4 – 6.7) were associated with PFA. Conclusions Overall preference for ACT use was low among health care providers in this study. Preference for ACTs and proportion of health workers with good knowledge of malaria case management were even lower among PPMVs who had highest proportion of those who received malaria case management training. We recommend evaluation of current training quality, enhanced targeted training, follow-up supportive supervision of PPMVs and behavior change communication on ACT use.
first_indexed 2024-12-12T08:30:31Z
format Article
id doaj.art-8670e675ce8141419ab4a48c2e6e21a3
institution Directory Open Access Journal
issn 2397-0642
language English
last_indexed 2024-12-12T08:30:31Z
publishDate 2019-01-01
publisher BMC
record_format Article
series Global Health Research and Policy
spelling doaj.art-8670e675ce8141419ab4a48c2e6e21a32022-12-22T00:31:07ZengBMCGlobal Health Research and Policy2397-06422019-01-01411810.1186/s41256-018-0092-9Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central NigeriaSylvanus C. Welle0Olufemi Ajumobi1Magbagbeola Dairo2Muhammad Balogun3Peter Adewuyi4Babatunde Adedokun5Patrick Nguku6Saheed Gidado7IkeOluwapo Ajayi8Division of Health Promotion, Department of Family Health, Federal Ministry of HealthNigeria Field Epidemiology and Laboratory Training ProgrammeDepartment of Epidemiology and Medical Statistics, University of IbadanNigeria Field Epidemiology and Laboratory Training ProgrammeLiberia Field Epidemiology Training ProgrammeDepartment of Epidemiology and Medical Statistics, University of IbadanNigeria Field Epidemiology and Laboratory Training ProgrammeNigeria Field Epidemiology and Laboratory Training ProgrammeNigeria Field Epidemiology and Laboratory Training ProgrammeAbstract Background In Nigeria, Artemisinin-based Combination Therapy (ACT) is the recommended first line antimalarial medicine for uncomplicated malaria. However, health care providers still continue the use of less efficacious medicines such as Sulphadoxine-pyrimethamine and chloroquine. We therefore determined preference for ACT (PFA) and factors associated with PFA among healthcare providers (HCP) in Lokoja, North-Central Nigeria as well as assessed healthcare providers’ knowledge of malaria case management. Methods We conducted a cross-sectional study among physicians, nurses, pharmacists, community health officers (CHOs), community health extension workers (CHEWs) and, patent and proprietary medicine vendors (PPMVs). Interviewer-administered questionnaires were administered to collect data on respondents’ characteristics, previously received malaria case management training and knowledge of malaria treatment. Knowledge scores ≥3 were categorised as good, maximum obtainable being 5. Results Of the 404 respondents, 214 (53.0%) were males. Overall, 219 (54.2%) respondents who received malaria case management training  included PPMVs: 79 (65.8%), CHEWs: 25 (64.1%), CHOs: 5 (55.6%), nurses: 72 (48.7%), physicians: 35 (47.3%) and pharmacists: 3 (23.1%). Overall, 202 (50.0%) providers including physicians: 69 (93.2%), CHO: 8 (88.9%), CHEWs: 33 (84.6%), pharmacists: 8 (61.5%), nurses: 64 (43.2%) and PPMVs: 20 (16.5%), had good knowledge of malaria treatment guidelines. Overall, preference for ACT among healthcare providers was 39.6%. Physicians: 50 (67.6%), pharmacists: 7 (59.3%) CHOs: 5 (55.6%), CHEWS: 16 (41.0%), nurses: 56 (37.8%) and PPMV: 24 (19.8%) had PFA. Receiving malaria case management training (adjusted odds ratio [aOR]) = 2.3; CI = 1.4 – 3.7) and having good knowledge of malaria treatment (aOR = 4.0; CI = 2.4 – 6.7) were associated with PFA. Conclusions Overall preference for ACT use was low among health care providers in this study. Preference for ACTs and proportion of health workers with good knowledge of malaria case management were even lower among PPMVs who had highest proportion of those who received malaria case management training. We recommend evaluation of current training quality, enhanced targeted training, follow-up supportive supervision of PPMVs and behavior change communication on ACT use.http://link.springer.com/article/10.1186/s41256-018-0092-9Artemisinin-based combination therapyPreference for ACTHealthcare providers
spellingShingle Sylvanus C. Welle
Olufemi Ajumobi
Magbagbeola Dairo
Muhammad Balogun
Peter Adewuyi
Babatunde Adedokun
Patrick Nguku
Saheed Gidado
IkeOluwapo Ajayi
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Global Health Research and Policy
Artemisinin-based combination therapy
Preference for ACT
Healthcare providers
title Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
title_full Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
title_fullStr Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
title_full_unstemmed Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
title_short Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
title_sort preference for artemisinin based combination therapy among healthcare providers lokoja north central nigeria
topic Artemisinin-based combination therapy
Preference for ACT
Healthcare providers
url http://link.springer.com/article/10.1186/s41256-018-0092-9
work_keys_str_mv AT sylvanuscwelle preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT olufemiajumobi preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT magbagbeoladairo preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT muhammadbalogun preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT peteradewuyi preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT babatundeadedokun preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT patricknguku preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT saheedgidado preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria
AT ikeoluwapoajayi preferenceforartemisininbasedcombinationtherapyamonghealthcareproviderslokojanorthcentralnigeria